Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

3.11
+0.11003.67%
Volume:29.03K
Turnover:88.98K
Market Cap:50.54M
PE:-13.87
High:3.11
Open:2.99
Low:2.99
Close:3.00
Loading ...
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 07, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 01, 2023

Correspondence

Form CORRESP - Correspondence
Jun 01, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Correspondence

Form CORRESP - Correspondence
May 10, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 24, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 24, 2023

Major Issues Report

8-K - Current report
Apr 03, 2023

Major Issues Report

8-K/A [Amend] - Current report
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2023

Major Issues Report

8-K - Current report
Feb 24, 2023

Major Issues Report

8-K - Current report
Feb 16, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 21, 2022

Major Issues Report

8-K - Current report